TEST BANK FOR
PHARMACOLOGY A PATIENT-CENTERED NURSING
PROCESS APPROACH, 11TH EDITION
BY LINDA E. MCCUISTION | VERIFIED CHAPTER'S 1 -
58 | COMPLETE ANSWERS
,
,TABLE OF CONTENTS
CHAPTER 01: THE NURSING PROCESS AND PATIENT-CENTERED CARE ................... 6
CHAPTER 02: DRUG DEVELOPMENT AND ETHICAL CONSIDERATIONS.................. 13
CHAPTER 03: PHARMACOKINETICS AND PHARMACODYNAMICS ......................... 23
CHAPTER 04: PHARMACOGENETICS ..................................................................... 42
CHAPTER 05: COMPLEMENTARY AND ALTERNATIVE THERAPIES ......................... 46
CHAPTER 06: PEDIATRIC CONSIDERATIONS.......................................................... 53
CHAPTER 07: GERIATRIC CONSIDERATIONS ......................................................... 61
CHAPTER 08: DRUGS IN SUBSTANCE USE DISORDER ............................................ 68
CHAPTER 09: SAFETY AND QUALITY ..................................................................... 76
CHAPTER 10: DRUG ADMINISTRATION ................................................................ 84
CHAPTER 11: DRUG CALCULATIONS ..................................................................... 91
CHAPTER 12: FLUID VOLUME AND ELECTROLYTES ............................................... 96
CHAPTER 13: VITAMIN AND MINERAL REPLACEMENT ....................................... 108
CHAPTER 14: NUTRITIONAL SUPPORT ................................................................ 117
CHAPTER 15: ADRENERGIC AGONISTS AND ANTAGONISTS ................................ 127
CHAPTER 16: CHOLINERGIC AGONISTS AND ANTAGONISTS ............................... 135
CHAPTER 17: STIMULANTS................................................................................. 143
CHAPTER 18: DEPRESSANTS ............................................................................... 149
CHAPTER 19: ANTISEIZURE DRUGS .................................................................... 157
CHAPTER 20: DRUGS FOR PARKINSONISM AND ALZHEIMER DISEASE ................ 166
CHAPTER 21: DRUGS FOR NEUROMUSCULAR DISORDERS AND MUSCLE SPASMS
........................................................................................................................... 175
CHAPTER 22: ANTIPSYCHOTICS AND ANXIOLYTICS ............................................. 182
CHAPTER 23: ANTIDEPRESSANTS AND MOOD STABILIZERS ............................... 192
CHAPTER 24: ANTIINFLAMMATORIES ................................................................ 201
CHAPTER 25: ANALGESICS.................................................................................. 210
CHAPTER 26: PENICILLINS, OTHER BETA-LACTAMS, AND CEPHALOSPORINS ...... 219
, CHAPTER 27: MACROLIDES, OXAZOLIDINONES, LINCOSAMIDES, GLYCOPEPTIDES,
KETOLIDES, AND LIPOPEPTIDES.......................................................................... 226
CHAPTER 28: TETRACYCLINES, GLYCYLCYCLINES, AMINOGLYCOSIDES, AND
FLUOROQUINOLONES ........................................................................................ 231
CHAPTER 29: SULFONAMIDES AND NITROIMIDAZOLES ANTIBIOTICS ................ 236
CHAPTER 30: ANTITUBERCULARS, ANTIFUNGALS, AND ANTIVIRALS .................. 242
CHAPTER 31: ANTIMALARIALS, ANTHELMINTICS, AND PEPTIDES ....................... 252
CHAPTER 32: HIV- AND AIDS-RELATED DRUGS ................................................... 257
CHAPTER 33: TRANSPLANT DRUGS .................................................................... 262
CHAPTER 34: VACCINES ..................................................................................... 265
CHAPTER 35: ANTICANCER DRUGS..................................................................... 271
CHAPTER 36: TARGETED THERAPIES TO TREAT CANCER .................................... 277
CHAPTER 37: BIOLOGIC RESPONSE MODIFIERS .................................................. 282
CHAPTER 38: UPPER RESPIRATORY DISORDERS ................................................. 288
CHAPTER 39: LOWER RESPIRATORY DISORDERS ................................................ 295
CHAPTER 40: CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS304
CHAPTER 41: DIURETICS..................................................................................... 316
CHAPTER 42: ANTIHYPERTENSIVES .................................................................... 322
CHAPTER 43: ANTICOAGULANTS, ANTIPLATELETS, AND THROMBOLYTICS ........ 331
CHAPTER 44: ANTIHYPERLIPIDEMICS AND DRUGS TO IMPROVE PERIPHERAL
BLOOD FLOW ..................................................................................................... 342
CHAPTER 45: GASTROINTESTINAL TRACT DISORDERS ........................................ 350
CHAPTER 46: ANTIULCER DRUGS ....................................................................... 361
CHAPTER 47: EYE AND EAR DISORDERS ............................................................. 369
CHAPTER 48: DERMATOLOGIC DISORDERS ........................................................ 375
CHAPTER 49: PITUITARY, THYROID, PARATHYROID, AND ADRENAL DISORDERS 383
CHAPTER 50: ANTIDIABETICS ............................................................................. 395
CHAPTER 51: URINARY DISORDERS .................................................................... 405
PHARMACOLOGY A PATIENT-CENTERED NURSING
PROCESS APPROACH, 11TH EDITION
BY LINDA E. MCCUISTION | VERIFIED CHAPTER'S 1 -
58 | COMPLETE ANSWERS
,
,TABLE OF CONTENTS
CHAPTER 01: THE NURSING PROCESS AND PATIENT-CENTERED CARE ................... 6
CHAPTER 02: DRUG DEVELOPMENT AND ETHICAL CONSIDERATIONS.................. 13
CHAPTER 03: PHARMACOKINETICS AND PHARMACODYNAMICS ......................... 23
CHAPTER 04: PHARMACOGENETICS ..................................................................... 42
CHAPTER 05: COMPLEMENTARY AND ALTERNATIVE THERAPIES ......................... 46
CHAPTER 06: PEDIATRIC CONSIDERATIONS.......................................................... 53
CHAPTER 07: GERIATRIC CONSIDERATIONS ......................................................... 61
CHAPTER 08: DRUGS IN SUBSTANCE USE DISORDER ............................................ 68
CHAPTER 09: SAFETY AND QUALITY ..................................................................... 76
CHAPTER 10: DRUG ADMINISTRATION ................................................................ 84
CHAPTER 11: DRUG CALCULATIONS ..................................................................... 91
CHAPTER 12: FLUID VOLUME AND ELECTROLYTES ............................................... 96
CHAPTER 13: VITAMIN AND MINERAL REPLACEMENT ....................................... 108
CHAPTER 14: NUTRITIONAL SUPPORT ................................................................ 117
CHAPTER 15: ADRENERGIC AGONISTS AND ANTAGONISTS ................................ 127
CHAPTER 16: CHOLINERGIC AGONISTS AND ANTAGONISTS ............................... 135
CHAPTER 17: STIMULANTS................................................................................. 143
CHAPTER 18: DEPRESSANTS ............................................................................... 149
CHAPTER 19: ANTISEIZURE DRUGS .................................................................... 157
CHAPTER 20: DRUGS FOR PARKINSONISM AND ALZHEIMER DISEASE ................ 166
CHAPTER 21: DRUGS FOR NEUROMUSCULAR DISORDERS AND MUSCLE SPASMS
........................................................................................................................... 175
CHAPTER 22: ANTIPSYCHOTICS AND ANXIOLYTICS ............................................. 182
CHAPTER 23: ANTIDEPRESSANTS AND MOOD STABILIZERS ............................... 192
CHAPTER 24: ANTIINFLAMMATORIES ................................................................ 201
CHAPTER 25: ANALGESICS.................................................................................. 210
CHAPTER 26: PENICILLINS, OTHER BETA-LACTAMS, AND CEPHALOSPORINS ...... 219
, CHAPTER 27: MACROLIDES, OXAZOLIDINONES, LINCOSAMIDES, GLYCOPEPTIDES,
KETOLIDES, AND LIPOPEPTIDES.......................................................................... 226
CHAPTER 28: TETRACYCLINES, GLYCYLCYCLINES, AMINOGLYCOSIDES, AND
FLUOROQUINOLONES ........................................................................................ 231
CHAPTER 29: SULFONAMIDES AND NITROIMIDAZOLES ANTIBIOTICS ................ 236
CHAPTER 30: ANTITUBERCULARS, ANTIFUNGALS, AND ANTIVIRALS .................. 242
CHAPTER 31: ANTIMALARIALS, ANTHELMINTICS, AND PEPTIDES ....................... 252
CHAPTER 32: HIV- AND AIDS-RELATED DRUGS ................................................... 257
CHAPTER 33: TRANSPLANT DRUGS .................................................................... 262
CHAPTER 34: VACCINES ..................................................................................... 265
CHAPTER 35: ANTICANCER DRUGS..................................................................... 271
CHAPTER 36: TARGETED THERAPIES TO TREAT CANCER .................................... 277
CHAPTER 37: BIOLOGIC RESPONSE MODIFIERS .................................................. 282
CHAPTER 38: UPPER RESPIRATORY DISORDERS ................................................. 288
CHAPTER 39: LOWER RESPIRATORY DISORDERS ................................................ 295
CHAPTER 40: CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS304
CHAPTER 41: DIURETICS..................................................................................... 316
CHAPTER 42: ANTIHYPERTENSIVES .................................................................... 322
CHAPTER 43: ANTICOAGULANTS, ANTIPLATELETS, AND THROMBOLYTICS ........ 331
CHAPTER 44: ANTIHYPERLIPIDEMICS AND DRUGS TO IMPROVE PERIPHERAL
BLOOD FLOW ..................................................................................................... 342
CHAPTER 45: GASTROINTESTINAL TRACT DISORDERS ........................................ 350
CHAPTER 46: ANTIULCER DRUGS ....................................................................... 361
CHAPTER 47: EYE AND EAR DISORDERS ............................................................. 369
CHAPTER 48: DERMATOLOGIC DISORDERS ........................................................ 375
CHAPTER 49: PITUITARY, THYROID, PARATHYROID, AND ADRENAL DISORDERS 383
CHAPTER 50: ANTIDIABETICS ............................................................................. 395
CHAPTER 51: URINARY DISORDERS .................................................................... 405
